Annual Accounts Receivable
$2.90 M
+$326.00 K+12.67%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual accounts receivable is $2.90 million, with the most recent change of +$326.00 thousand (+12.67%) on March 31, 2024.
- During the last 3 years, SNOA annual accounts receivable has risen by +$92.00 thousand (+3.28%).
- SNOA annual accounts receivable is now -27.06% below its all-time high of $3.97 million, reached on March 31, 2020.
Performance
SNOA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$2.40 M
-$752.00 K-23.82%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly accounts receivable is $2.40 million, with the most recent change of -$752.00 thousand (-23.82%) on December 31, 2024.
- Over the past year, SNOA quarterly accounts receivable has dropped by -$471.00 thousand (-16.38%).
- SNOA quarterly accounts receivable is now -54.44% below its all-time high of $5.28 million, reached on September 30, 2020.
Performance
SNOA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SNOA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.7% | -16.4% |
| 3 y3 years | +3.3% | -6.5% |
| 5 y5 years | -16.8% | -6.5% |
SNOA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.4% | -25.9% | +8.2% |
| 5 y | 5-year | -27.1% | +20.4% | -54.4% | +8.2% |
| alltime | all time | -27.1% | +1176.7% | -54.4% | +959.5% |
Sonoma Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.40 M(-23.8%) |
| Sep 2024 | - | $3.16 M(-2.8%) |
| Jun 2024 | - | $3.25 M(+12.0%) |
| Mar 2024 | $2.90 M(+12.7%) | $2.90 M(+0.8%) |
| Dec 2023 | - | $2.88 M(+29.4%) |
| Sep 2023 | - | $2.22 M(-8.9%) |
| Jun 2023 | - | $2.44 M(-5.2%) |
| Mar 2023 | $2.57 M(+6.9%) | $2.57 M(+12.0%) |
| Dec 2022 | - | $2.30 M(-7.6%) |
| Sep 2022 | - | $2.49 M(+2.2%) |
| Jun 2022 | - | $2.43 M(+1.1%) |
| Mar 2022 | $2.41 M(-14.2%) | $2.41 M(-15.7%) |
| Dec 2021 | - | $2.85 M(-16.5%) |
| Sep 2021 | - | $3.42 M(+13.9%) |
| Jun 2021 | - | $3.00 M(+6.8%) |
| Mar 2021 | $2.81 M(-29.4%) | $2.81 M(-36.3%) |
| Dec 2020 | - | $4.41 M(-16.5%) |
| Sep 2020 | - | $5.28 M(+1.1%) |
| Jun 2020 | - | $5.22 M(+31.4%) |
| Mar 2020 | $3.97 M(+14.1%) | $3.97 M(-21.0%) |
| Dec 2019 | - | $5.03 M(+6.2%) |
| Sep 2019 | - | $4.74 M(+9.7%) |
| Jun 2019 | - | $4.32 M(+24.0%) |
| Mar 2019 | $3.48 M(+126.5%) | $3.48 M(+11.5%) |
| Dec 2018 | - | $3.12 M(+5.0%) |
| Sep 2018 | - | $2.97 M(+34.2%) |
| Jun 2018 | - | $2.21 M(+44.0%) |
| Mar 2018 | $1.54 M(-27.1%) | $1.54 M(-41.1%) |
| Dec 2017 | - | $2.61 M(-14.0%) |
| Sep 2017 | - | $3.04 M(+10.7%) |
| Jun 2017 | - | $2.74 M(+30.0%) |
| Mar 2017 | $2.11 M(+39.8%) | $2.11 M(+6.6%) |
| Dec 2016 | - | $1.98 M(-12.5%) |
| Sep 2016 | - | $2.26 M(-12.8%) |
| Jun 2016 | - | $2.59 M(+71.9%) |
| Mar 2016 | $1.51 M | $1.51 M(-45.0%) |
| Dec 2015 | - | $2.74 M(+6.6%) |
| Sep 2015 | - | $2.57 M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $2.54 M(+67.4%) |
| Mar 2015 | $1.52 M(-15.3%) | $1.52 M(+7.1%) |
| Dec 2014 | - | $1.42 M(-34.1%) |
| Sep 2014 | - | $2.15 M(+10.0%) |
| Jun 2014 | - | $1.95 M(+9.2%) |
| Mar 2014 | $1.79 M(+4.9%) | $1.79 M(-31.2%) |
| Dec 2013 | - | $2.60 M(+7.4%) |
| Sep 2013 | - | $2.42 M(+10.6%) |
| Jun 2013 | - | $2.19 M(+28.4%) |
| Mar 2013 | $1.71 M(-20.6%) | $1.71 M(-44.4%) |
| Dec 2012 | - | $3.07 M(+8.0%) |
| Sep 2012 | - | $2.84 M(-13.1%) |
| Jun 2012 | - | $3.27 M(+52.1%) |
| Mar 2012 | $2.15 M(+2.7%) | $2.15 M(+12.0%) |
| Dec 2011 | - | $1.92 M(-7.4%) |
| Sep 2011 | - | $2.07 M(+0.5%) |
| Jun 2011 | - | $2.06 M(-1.5%) |
| Mar 2011 | $2.09 M(+47.9%) | $2.09 M(+21.6%) |
| Dec 2010 | - | $1.72 M(+6.6%) |
| Sep 2010 | - | $1.61 M(+10.3%) |
| Jun 2010 | - | $1.46 M(+3.4%) |
| Mar 2010 | $1.42 M(+53.4%) | $1.42 M(+25.1%) |
| Dec 2009 | - | $1.13 M(+10.8%) |
| Sep 2009 | - | $1.02 M(-21.0%) |
| Jun 2009 | - | $1.29 M(+40.1%) |
| Mar 2009 | $923.00 K(+19.9%) | $923.00 K(+5.1%) |
| Dec 2008 | - | $878.00 K(-2.4%) |
| Sep 2008 | - | $900.00 K(+5.1%) |
| Jun 2008 | - | $856.00 K(+11.2%) |
| Mar 2008 | $770.00 K(-43.5%) | $770.00 K(-20.9%) |
| Dec 2007 | - | $974.00 K(-14.8%) |
| Sep 2007 | - | $1.14 M(-11.8%) |
| Jun 2007 | - | $1.30 M(-5.0%) |
| Mar 2007 | $1.36 M(+26.8%) | $1.36 M(-15.4%) |
| Dec 2006 | - | $1.61 M(-5.2%) |
| Sep 2006 | - | $1.70 M(+58.1%) |
| Mar 2006 | $1.08 M(+374.0%) | $1.08 M(+374.0%) |
| Mar 2005 | $227.00 K | $227.00 K |
FAQ
- What is Sonoma Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual accounts receivable year-on-year change?
- What is Sonoma Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Sonoma Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of SNOA is $2.90 M
What is the all time high annual accounts receivable for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual accounts receivable is $3.97 M
What is Sonoma Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, SNOA annual accounts receivable has changed by +$326.00 K (+12.67%)
What is Sonoma Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of SNOA is $2.40 M
What is the all time high quarterly accounts receivable for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly accounts receivable is $5.28 M
What is Sonoma Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, SNOA quarterly accounts receivable has changed by -$471.00 K (-16.38%)